SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000932471-17-001931
Filing Date
2017-02-10
Accepted
2017-02-10 14:20:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 theravancebiopharmainc.htm SC 13G 46937
  Complete submission text file 0000932471-17-001931.txt   48457
Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600
Business Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 6106691000
VANGUARD GROUP INC (Filed by) CIK: 0000102909 (see all company filings)

IRS No.: 231945930 | State of Incorp.: PA | Fiscal Year End: 1231
Type: SC 13G

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Subject) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88552 | Film No.: 17592159
SIC: 2834 Pharmaceutical Preparations